Synthesized Polymers-Functionalized PEG
Synthesized Polymers-Functionalized PEG
Seebio Biotech, Inc. provides a variety of Synthesized Polymers such as Functionalized Polystyrene (PS), Functionalized Polyisoprene (PI), Functionalized Polyvinylpyridine ,block Copolymer(33) and so on.
Please contact us for more natural or synthesized polymers.
Product Detail:
1. Functionalized PEG (262)
No.
Description
Structure
1
mPEO-OH
2
mPEO-COOH
3
mPEO-COOH
4
mPEO-COOH
5
mPEO-SC
6
mPEO-SCM
7
mPEO-SPA
8
mPEO-SS
9
mPEO-ALD
10
mPEO-ALD
11
mPEO-ALD
12
mPEO-NH2
13
mPEO-NH2
14
mPEO-MAL
15
mPEO-MAL
16
mPEO-SH
17
mPEO- Propargyl
18
mPEO-Allyl
19
mPEO- Acryloyl
20
mPEO-Br
21
mPEO-TEMPO
22
mPEO-OTS
23
mPEO-N3
Parameters:
Molecular Weight Range, 500-500,000Da
PDI, ≤1.08
Package: 1mg-5000g
1.1 Monofunctional PEG(23)
1.2 Bifunctional PEG (23)
|
No. |
Description |
Structure |
|
1 |
HO-PEG-OH |
|
|
2 |
HOOC-PEG-COOH |
|
|
3 |
HOOC-PEG-COOH |
|
|
4 |
HOOC-PEG-COOH |
|
|
5 |
SC-PEG-SC |
|
|
6 |
SCM-PEG-SCM |
|
|
7 |
SPA-PEG-SPA |
|
|
8 |
SS-PEG-SS |
|
|
9 |
ALD-PEG-ALD |
|
|
10 |
ALD-PEG-ALD |
|
|
11 |
ALD-PEG-ALD |
|
|
12 |
NH2-PEG-NH2 |
|
|
13 |
NH2-PEG-NH2 |
|
|
14 |
MAL-PEG-MAL |
|
|
15 |
MAL-PEG-MAL |
|
|
16 |
HS-PEG-SH |
|
|
17 |
Propargyl-PEG-Propargyl |
|
|
18 |
Allyl -PEG-Allyl |
|
|
19 |
Acryloyl-PEG-Acryloyl |
|
|
20 |
Br-PEG-Br |
|
|
21 |
TEMPO-PEG-TEMPO |
|
|
22 |
OTS-PEG-OTS |
|
|
23 |
N3-PEG- N3 |
|
1.3 Heterofunctional PEG (69)
|
No. |
Description |
Structure |
|
1 |
HO-PEG-COOH |
|
|
2 |
HO-PEG- COOH |
|
|
3 |
HO-PEG- ALD |
|
|
4 |
HO-PEG- ALD |
|
|
5 |
HO-PEG- ALD |
|
|
6 |
HO-PEG- NH2 |
|
|
7 |
HO-PEG- MAL |
|
|
8 |
HO-PEG- SH |
|
|
9 |
HO-PEG- Propargyl |
|
|
10 |
HO-PEG- Allyl |
|
|
11 |
HO-PEG- TEMPO |
|
|
12 |
ALD-PEG- COOH |
|
|
13 |
ALD-PEG- COOH |
|
|
14 |
ALD-PEG- SH |
|
|
15 |
ALD-PEG- Propargyl |
|
|
16 |
ALD-PEG- Allyl |
|
|
17 |
ALD-PEG- TEMPO |
|
|
18 |
ALD-PEG- COOH |
|
|
19 |
ALD-PEG- COOH |
|
|
20 |
ALD-PEG- SH |
|
|
21 |
ALD-PEG- Propargyl |
|
|
22 |
ALD-PEG- Allyl |
|
|
23 |
ALD-PEG- TEMPO |
|
|
24 |
ALD-PEG- COOH |
|
|
25 |
ALD-PEG- COOH |
|
|
26 |
ALD-PEG-SH |
|
|
27 |
ALD-PEG- Propargyl |
|
|
28 |
ALD-PEG- Allyl |
|
|
29 |
ALD-PEG-TEMPO |
|
|
30 |
TEMPO-PEG-OH |
|
|
31 |
TEMPO-PEG-COOH |
|
|
32 |
TEMPO-PEG-COOH |
|
|
33 |
TEMPO-PEG-COOH |
|
|
34 |
TEMPO-PEG-SC |
|
|
35 |
TEMPO-PEG-SCM |
|
|
36 |
TEMPO-PEG-SPA |
|
|
37 |
TEMPO-PEG-SS |
|
|
38 |
TEMPO-PEG-ALD |
|
|
39 |
TEMPO-PEG-ALD |
|
|
40 |
TEMPO-PEG-ALD |
|
|
41 |
TEMPO-PEG-SH |
|
|
42 |
TEMPO-PEG-Propargyl |
|
|
43 |
TEMPO-PEG-Allyl |
|
|
44 |
TEMPO-PEG- Acryloyl |
|
|
45 |
TEMPO-PEG- Br |
|
|
46 |
TEMPO-PEG- OTs |
|
|
47 |
TEMPO-PEG- N3 |
|
|
48 |
Allyl-PEG-COOH |
|
|
49 |
Allyl-PEG-COOH |
|
|
50 |
Allyl-PEG-COOH |
|
|
51 |
Allyl-PEG-SC |
|
|
52 |
Allyl-PEG-SCM |
|
|
53 |
Allyl-PEG-SPA |
|
|
54 |
Allyl-PEG-SS |
|
|
55 |
Allyl-PEG-ALD |
|
|
56 |
Allyl-PEG-ALD |
|
|
57 |
Allyl-PEG-ALD |
|
|
58 |
Allyl-PEG- SH |
|
|
59 |
Allyl-PEG-Propargyl |
|
|
60 |
Allyl-PEG- Acryloyl |
|
|
61 |
Allyl-PEG-Br |
|
|
62 |
Allyl-PEG-OTs |
|
|
63 |
Allyl-PEG-N3 |
|
|
64 |
HOOC-PEG-OH |
|
|
65 |
HOOC-PEG-OH |
|
|
66 |
NH2-PEG-OH |
|
|
67 |
NH2-PEG-COOH |
|
|
68 |
NH2-PEG-OH |
|
|
69 |
NH2-PEG-COOH |
|
1.4 2-Armed V-shaped PEG (45)
|
No. |
Description |
Structure |
|
1 |
(HOOC-PEO)2-OH |
|
|
2 |
(HOOC-PEO)2-OH |
|
|
3 |
(ALD-PEO)2-OH |
|
|
4 |
(ALD-PEO)2-OH |
|
|
5 |
(ALD-PEO)2-OH |
|
|
6 |
(Propargyl-PEO)2-OH |
|
|
7 |
(Allyl-PEO)2-OH |
|
|
8 |
(TEMPO-PEO)2-OH |
|
|
9 |
(mPEO)2-OH |
|
|
10 |
(mPEO)2-COOH |
|
|
11 |
(mPEO)2-COOH |
|
|
12 |
(mPEO)2-COOH |
|
|
13 |
(mPEO)2-SC |
|
|
14 |
(mPEO)2-SCM |
|
|
15 |
(mPEO)2-SPA |
|
|
16 |
(mPEO)2-SS |
|
|
17 |
(mPEO)2-ALD |
|
|
18 |
(mPEO)2- ALD |
|
|
19 |
(mPEO)2- ALD |
|
|
20 |
(mPEO)2-NH2 |
|
|
21 |
(mPEO)2- NH2 |
|
|
22 |
(mPEO)2-MAL |
|
|
23 |
(mPEO) 2-MAL |
|
|
24 |
(mPEO)2-SH |
|
|
25 |
(mPEO)2-Propargyl |
|
|
26 |
(mPEO)2-Allyl |
|
|
27 |
(mPEO)2- Acryloyl |
|
|
28 |
(mPEO)2-Br |
|
|
29 |
(mPEO)2-TEMOPO |
|
|
30 |
(mPEO)2-Ts |
|
|
31 |
(mPEO)2-N3 |
|
|
32 |
(HOOC-PEO)2-Allyl |
|
|
33 |
(HOOC-PEO)2-Allyl |
|
|
34 |
(Propargyl-PEO)2-Allyl |
|
|
35 |
(HO-PEO)2-COOH |
|
|
36 |
(HO-PEO)2-COOH |
|
|
37 |
(HO-PEO)2-NH2 |
|
|
38 |
(HOOC-PEO)2- NH2 |
|
|
39 |
(HOOC-PEO)2- NH2 |
|
|
40 |
(HOOC-PEO)2-OH |
|
|
41 |
(HOOC-PEO)2-OH |
|
|
42 |
(mPEO)2-COOH |
|
|
43 |
(mPEO)2-COOH |
|
|
44 |
(mPEO)2-NH2 |
|
|
45 |
(mPEO)2-OH |
|
1.5 3-Armed Y-shaped PEG (15)
|
No. |
Description |
Structure |
|
1 |
(mPEO)2-(PEO-OH) |
|
|
2 |
(mPEO)2-(PEO-COOH) |
|
|
3 |
(mPEO) 2-(PEO-SC) |
|
|
4 |
(mPEO) 2-(PEO-SPA) |
|
|
5 |
(mPEO) 2-(PEO-MAL) |
|
|
6 |
(mPEO)2-(PEO-ALD) |
|
|
7 |
(mPEO)2-(PEO-NH2) |
|
|
8 |
(mPEO) 2-(PEO-SH) |
|
|
9 |
(mPEO) 2-(PEO-Propargyl) |
|
|
10 |
(mPEO)2-(PEO-Allyl) |
|
|
11 |
(mPEO)2- (PEO-Acryloyl) |
|
|
12 |
(mPEO) 2- (PEO-Br) |
|
|
13 |
(mPEO)2- (PEO-TEMPO) |
|
|
14 |
(mPEO)2- (PEO-Ts) |
|
|
15 |
(mPEO) 2- (PEO-N3) |
|
1.6 3-Armed V-shaped PEG (15)
|
No. |
Description |
Structure |
|
1 |
(mPEO)3-OH 3-(PEO-OH) |
|
|
2 |
(mPEO)3-COOH 3-(PEO-COOH) |
|
|
3 |
(mPEO)3-SC3-(PEO-SC) |
|
|
4 |
(mPEO)3-SPA(mPEO)3-(PEO-SPA) |
|
|
5 |
(mPEO)3-MAL3-(PEO-MAL) |
|
|
6 |
(mPEO)3-ALD 3-(PEO-ALD) |
|
|
7 |
(mPEO)3-NH23-(PEO-NH2) |
|
|
8 |
(mPEO)3-SH3-(PEO-SH) |
|
|
9 |
(mPEO)3-Propargyl3-(PEO-Propargyl) |
|
|
10 |
(mPEO)3-Allyl3-(PEO-Allyl) |
|
|
11 |
(mPEO)3-Acryloyl- (PEO-Acryloyl) 3 |
|
|
12 |
(mPEO)3-Br3- (PEO-Br) |
|
|
13 |
(mPEO)3-TEMPO3- (PEO-TEMPO) |
|
|
14 |
(mPEO)3-Ts 3- (PEO-Ts)(mPEO)3-N3 |
|
|
15 |
(mPEO)3- (PEO-N 3) |
|
1.7 4-Armed Y-shaped PEG (15)
|
No. |
Description |
Structure |
|
1 |
(mPEO)3-(PEO-OH)2-(PEO-OH) |
|
|
2 |
(mPEO)3-(PEO-COOH)2-(PEO-COOH) |
|
|
3 |
(mPEO)3-(PEO-SC) 2-(PEO-SC) |
|
|
4 |
(mPEO)3-(PEO-SPA) 2-(PEO-SPA) |
|
|
5 |
(mPEO)3-(PEO-MAL)(mPEO)2-(PEO-MAL) |
|
|
6 |
(mPEO)3-(PEO-ALD)2-(PEO-ALD) |
|
|
7 |
(mPEO)3-(PEO-NH2) 2-(PEO-NH2) |
|
|
8 |
(mPEO)3-(PEO-SH)2-(PEO-SH) |
|
|
9 |
(mPEO)3-(PEO-2-(PEO-Propargyl Propargyl)) |
|
|
10 |
(mPEO)3-(PEO-Allyl) 2-(PEO-Allyl) |
|
|
11 |
(mPEO)3-(PEO-Acryloyl)2- (PEO-Acryloyl) |
|
|
12 |
(mPEO)3-(PEO-Br) 2- (PEO-Br) |
|
|
13 |
(mPEO)3-(PEO-TEMPO)2- (PEO-TEMPO) |
|
|
14 |
(mPEO)3-(PEO-Ts)(mPEO) 2- (PEO-Ts) |
|
|
15 |
(mPEO)3-(PEO-N3) 2- (PEO-N3) |
|
1.8 Dendrimer-like PEG (30)
|
No. |
Description |
Structure |
|
1 |
(mPEO) 4-(PEO)2-OH |
|
|
2 |
(mPEO) 4-(PEO)2-COOH |
|
|
3 |
(mPEO) 4-(PEO)2-SC |
|
|
4 |
(mPEO) 4-(PEO)2-SPA |
|
|
5 |
(mPEO) 4-(PEO)2-MAL |
|
|
6 |
(mPEO) 4-(PEO)2-ALD |
|
|
7 |
(mPEO) 4-(PEO)2-NH2 |
|
|
8 |
(mPEO) 4-(PEO)2-SH |
|
|
9 |
((mPEO) 4-(PEO)2-Propargyl |
|
|
10 |
(mPEO) 4-(PEO)2-Allyl |
|
|
11 |
(mPEO) 4-(PEO)2-Acryloyl |
|
|
12 |
(mPEO) 4-(PEO)2-Br |
|
|
13 |
(mPEO) 4-(PEO)2-TEMPO |
|
|
14 |
(mPEO) 4-(PEO)2-Ts |
|
|
15 |
(mPEO) 4-(PEO)2-N3 |
|
|
16 |
(mPEO) 4-(PEO)2-PEO-OH |
|
|
17 |
(mPEO) 4-(PEO)2-PEO-COOH |
|
|
18 |
(mPEO) 4-(PEO)2- PEO-SC |
|
|
19 |
(mPEO) 4-(PEO)2- PEO-SPA |
|
|
20 |
(mPEO) 4-(PEO)2-PEO-MAL |
|
|
21 |
(mPEO) 4-(PEO)2-PEO-ALD |
|
|
22 |
(mPEO) 4-(PEO)2- PEO-NH2 |
|
|
23 |
(mPEO) 4-(PEO)2- PEO-SH |
|
|
24 |
((mPEO)4-(PEO)2-PEO-Propargyl |
|
|
25 |
(mPEO) 4-(PEO)2-PEO-Allyl |
|
|
26 |
(mPEO) 4-(PEO)2-PEO-Acryloyl |
|
|
27 |
(mPEO) 4-(PEO)2- PEO-Br |
|
|
28 |
(mPEO) 4-(PEO)2-PEO-TEMPO |
|
|
29 |
(mPEO) 4-(PEO)2- PEO-Ts |
|
|
30 |
(mPEO) 4-(PEO)2- PEO-N3 |
|
1.9 3-Armed PEG (9)
|
No. |
Description |
Structure |
|
1 |
3Arm (PEO-OH) 3 |
|
|
2 |
3Arm (PEO-COOH)3 |
|
|
3 |
3Arm (PEO-SH)3 |
|
|
4 |
3Arm (PEO-NH2)3 |
|
|
5 |
3Arm (PEO-Propargyl) 3 |
|
|
6 |
3Arm (PEO- Allyl3 |
|
|
7 |
3Arm (PEO- Acryloyl )3 |
|
|
8 |
3Arm (PEO-Br )3 |
|
|
9 |
3Arm (PEO- N 3)3 |
|
1.10 4-Armed PEG (9)
|
No. |
Description |
Structure |
|
1 |
4Arm (PEO-OH)4 |
|
|
2 |
4Arm (PEO-COOH)4 |
|
|
3 |
4Arm (PEO-NH2)4 |
|
|
4 |
4Arm (PEO-SH)4 |
|
|
5 |
4Arm (PEO-Propargyl)4 |
|
|
6 |
4Arm (PEO- Allyl)4 |
|
|
7 |
4Arm (PEO- Acryloyl )4 |
|
|
8 |
4Arm (PEO-Br )4 |
|
|
9 |
4Arm (PEO- N3)4 |
|
1.11 6-Armed PEG (9)
|
No. |
Description |
Structure |
|
1 |
6Arm (PEO-OH) 6 |
|
|
2 |
6Arm (PEO-COOH) 6 |
|
|
3 |
6Arm (PEO-SH) 6 |
|
|
4 |
6Arm (PEO- NH 2)6 |
|
|
5 |
6Arm (PEO-Propargyl) 6 |
|
|
6 |
6Arm (PEO- Acryloyl )6 |
|
|
7 |
6Arm (PEO- Allyl ) 6 |
|
|
8 |
6Arm (PEO- Br)6 |
|
|
9 |
6Arm (PEO-N 3)6 |
|
1. A variety of functional groups, good performance, high-purity,Mw 500-80,000, Polydispersity Index(PDI)less than 1.05;
2. The production process is simplified, low impurity n ice stability;
3. More than 400 various types, nearly 2,000 kinds of product;
4. Customized products and service.
1. Functionalized PEG (262)
1.1 Monofunctional PEG(23)
1.2 Bifunctional PEG (23)
1.3 Heterofunctional PEG (69)
1.4 2-Armed V-shaped PEG (45)
1.5 3-Armed Y-shaped PEG (15)
1.6 3-Armed V-shaped PEG (15)
1.7 4-Armed Y-shaped PEG (15)
1.8 Dendrimer-like PEG (30)
1.9 3-Armed PEG (9)
1.10 4-Armed PEG (9)
1.11 6-Armed PEG (9)
2. Funcationlaized Subsititued Poly(ether) (12)
3. Functionalized Polystyrene (PS) (36)
4. Functionalized Polyisoprene (PI)(20)
5. Functionalized Polyvinylpyridine (PVP) (36)
Please contact us for more natural or synthesized polymers.
Seebio Biotech, Inc.
11-502. Lane 299, Bisheng Rd.
Zhangjiang High Tech Park
Shanghai 201204, P.R.China
Tel: 86-21-50272975, 76, 77, 78, 79, 81,Ext:6513,6515,6516,6520,6521,6522
For customers' complaint or suggestion： 86-21-50272981-6821, 6818
Web： www.seebio.cn
Email：fyland@seebio.cn service@seebio.cn
MSN：seebio8@hotmail.com
Skype：seebiocn
 |
 |
 |
| 官網：www.baichuan365.com | 微信服務號：iseebio | 微博：seebiobiotech |
 |
 |
 |
| 商城：mall.seebio.cn | 微信訂閱號：seebiotech | 泉養堂：www.canmedo.com |
相關資訊
- 人表面活性蛋白AElisa Kit
- 線性-樹枝狀聚合物 Linear-Dendritic Hybrids
- 好消息!上海西寶生物修飾性PEG “買一送一”
- 中國人類基因組研究有望“彎道超車”
- 肺癌的控制率可達100%！康方生物PD-1/VEGF雙抗AK112能否創造奇跡?
- 質譜校準標準品 Mass pectrometer Calibration Standard
- 中國腫瘤免疫療法低價時代來臨？
- PNAS：科學家開發出制造高效流感疫苗的新型有效方法
- 重磅：衛計委公布首批干細胞臨床研究機構備案名單
- 躺著睡還是趴著睡？不如側著睡，有利于預防老年癡呆！
新進產品
同類文章排行
- 膽堿酯酶檢測原料一覽
- 猴痘病毒檢測原料（涵蓋診斷酶、抗原、抗體），西寶生物助力猴痘檢測
- 西寶生物CHO細胞、HEK293細胞、 Vero細胞培養基產品
- 人和動物免疫球蛋白IgG全新上市
- 如何選擇合適的表面活性劑？
- 尿液分析試紙檢測原理及產品推薦
- 總膽紅素/直接膽紅素檢測一站式解決方案
- 分子診斷用酶原料一站式服務盡在西寶生物
- 體外診斷中交聯劑的用途與選擇
- 優異的化妝品級水溶性β-1,3-葡聚糖
資訊文章
您的瀏覽歷史
